The division is engaged in the following scholarly activities.

Research projects

  • Smart Monitor for the NICU: Adaptive System for the Detection and Prediction of Apnea, Desaturation and Bradycardia in Premature and Low Birth Weight Infants. Coulter Biomedical Accelerator at the University of Missouri.  $104,870 grant. Dates: 7/1/19 to present
  • NICU Automatic Oxygen Control with Parameter and Disturbance Estimation.  NIH grant $414,149. Dates:  4/10/20 to present
    Hou X, Faqeeh A, Amjad R, Pardalos J, Fales R.
    Clinical Evaluation of an Automatic Oxygen Control System for Premature Infants Receiving High-Flow Nasal Cannula for Respiratory Support: A Pilot Study
    JMed Device. 2022 Sep 1;16(3):031005.
    PMID: 35646226
    https://pubmed.ncbi.nlm.nih.gov/35646226/
  • MedImmune, Inc. – A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY).  Protocol No. D5290C00004.  Multicenter trial October, 2019 to present.        
  • MedImmune, Inc. – A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8896, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-risk Children (MEDLEY).  Protocol No. D5290C00005. Multicenter trial October, 2019 to present.

Completed research projects

Completed Quality Improvement Projects

Quality Improvement Projects

Improving Care of Infants with Neonatal Abstinence Syndrome

Project Leaders: Dr. Anjali Anders and Amy Lade, RN

Our institution is part of the Missouri Hospital Association-NAS QI Collaborative, which aims to improve care of infants with neonatal abstinence (or opiate withdrawal) syndrome. The goals of this QI include transition to Eat, Sleep Console method of assessment and management of the newborn; increasing non-pharmacological care; keeping mother-infant dyad intact; and validated screening of the mother for substance use disorders to provide early diagnosis and management of substance use disorders prenatally.